Top Undervalued Companies To Watch In Right Now

“I don’t know why this strategy isn’t written about more in the press,” Marty Sass innocently remarked. “Maybe it sounds too complicated."

The strategy to which Sass referred is “covered call option writing against attractive equities with growing dividends combined with the purchase of index put options for downside protection.”

Not complicated at all.

While it might sound facetious, when the CEO and chairman of independent investment management firm MD Sass with $8 billion under management, explained the strategy, it really is easily understood.

“It has three ingredients,” Sass told ThinkAdvisor on Thursday. “The first is buying undervalued, high quality stocks with better yields than the S&P 500 delivers. The second is selling covered calls with attractive premiums out of the money. The last is buying index puts out of the money for additional downside protection.”

Top Undervalued Companies To Watch In Right Now: ISTA Pharmaceuticals Inc.(ISTA)

ISTA Pharmaceuticals, Inc., a pharmaceutical company, discovers, develops, and markets remedies for diseases and conditions of the eye in the United States. It offers products to treat allergy and serious disease of the eye; and therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. The company provides BROMDAY for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extractions; BEPREVE for ocular itching associated with allergic conjunctivitis; ISTALOL for the treatment of glaucoma; and VITRASE for use as a spreading agent. Its products under development include T-Pred for steroid responsive inflammation and allergic conjunctivitis; Strong steroid for ocular inflammation; REMURA for the treatment of dry eye syndrome; and BROMDAY (lower concentration) for postoperative inflammation and reduction of ocular pain. The company?s products under development also comprise Bepotast ine nasal and Bepotastine nasal combination for allergic rhinitis. In addition, it is developing iganidipine to enhance ocular nerve blood flow; prostaglandin, a formulation of latanoprost, for the treatment of glaucoma; and ecabet sodium for dry eyes. ISTA Pharmaceuticals, Inc. sells its products to drug wholesalers, retailers, and distributors, such as chain of drug stores, hospitals, clinics, and government agencies, as well as health maintenance organizations and other institutions. The company was formerly known as Advanced Corneal Systems, Inc. and changed its name to ISTA Pharmaceuticals, Inc. in March 2000. ISTA Pharmaceuticals, Inc. was founded in 1992 and is headquartered in Irvine, California.

Advisors' Opinion:

• [By Mark]

  ISTA Pharmaceuticals, Inc. is a commercial stage, multi-specialty pharmaceutical company developing, marketing and selling its own products in the United States. Its EPS forecast for the current year is 0.17 and next year is 0.54. According to consensus estimates, its topline is expected to grow 16.65% current year and 19.17% next year. It is trading at a forward P/E of 19.85. Out of three analysts covering the company, two are positive and have buy recommendations and the other has a hold rating.

Top Undervalued Companies To Watch In Right Now: Avino Silver & Gold Mines Ltd. (ASM.V)

Avino Silver & Gold Mines Ltd. engages in the acquisition, exploration, and development of mineral properties in Canada and Mexico. It primarily explores for gold, silver, copper, zinc, and lead deposits. The company holds interest in the Avino Silver mine covering approximately 4,364 hectares located in Durango, Mexico. It also owns 100% interest in the Eagle property located in the Yukon, Canada; and the Aumax, Olympic-Kelvin, and Minto properties situated in British Columbia, Canada. Avino Silver & Gold Mines Ltd. was founded in 1968 and is headquartered in Vancouver, Canada.

Best Casino Stocks To Watch Right Now: Kingsmen Creatives Ltd(5MZ.SI)

Kingsmen Creatives Ltd., an investment holding company, provides integrated marketing solutions. The company?s Exhibitions and Museums segment produces exhibition displays for trade shows and promotional events; interiors and displays for museums and visitor centers; and thematic and scenic displays for theme parks. Its Interiors segment provides interior fitting-out services to commercial and retail properties. Kingsmen?s Research and Design segment offers design works for up market specialty stores, departmental stores, eateries, museums, visitors? centers, corporate offices, showrooms, trade shows, events, promotional functions, and festivals. The company?s Integrated Marketing Communication segment involves in the provision of event management and branding consultancy services. It also provides electrical engineering, graphic design and production services, advertising, and design consultancy and planning management, as well as design and construction facilities to exhibitors. The company operates primarily in Singapore, Greater China, the United States, Canada, Malaysia, rest of Asia, Europe, Vietnam, Indonesia, and the Middle East. Kingsmen Creatives Ltd. was founded in 1976 and is based in Singapore.